Frank Kung — Investment Profile

Q: Does Frank Kung invest at Venture stage?

Frank Kung invests at Venture, Private Equity stage.

Home › Investor Directory › Healthcare › Frank Kung

Frank Kung

Co-Founder and Managing Partner at Vivo Capital · Palo Alto, California, United States

Active now

Check size

Undisclosed

Lead stage

Venture

Deals tracked

Sectors

Healthcare, Biotechnology

Healthcare Biotechnology Life Sciences Medical Devices Venture Private Equity Public Equity

United States China Asia Singapore

About Frank

Frank Kung is an Executive Officer with a professional background in investment and business development. Limited public information is available regarding his current firm affiliation, specific investment stage focus, or sector specialization based on the provided data sources

Investment thesis

Healthcare and biotechnology venture investor focused on multi-stage global opportunities

Investing in transformative healthcare and biotechnology companies with global multi-stage platform approach

Investment philosophy

Vivo Capital, founded by Dr. Frank Kung in 1996, is a leading healthcare and biotechnology investment firm with $5.3 billion in assets under management. The firm focuses on making public and private investments across the healthcare and biotechnology industries, leveraging deep scientific expertise and global market access to drive innovation and value creation in the sector.

Recent activity

Jun 2026 Filed Form D — Investment vehicle · $0 raised

Live platform data · proprietary, citable layer

Notable portfolio

Bolt (BOLT)

Frequently asked

Does Frank Kung invest at Venture stage?

Yes. They invest at Venture, Private Equity, Public Equity stage. Their geographic focus includes United States, China, Asia.

What is their typical check size?

Check size is not publicly disclosed. They currently invest through Vivo Capital.

What sectors does Frank Kung focus on?

Frank Kung primarily invests in Healthcare, Biotechnology, Life Sciences, Medical Devices.